About This EventAgomAb Therapeutics NV (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results